Latest Updates
-
Bengali Style Urad Dal Recipe: A Comforting Lunch -
World Clubfoot Day 2026: How 'See Early, Treat Early, Run Free' Can Change A Child's Life -
World Bicycle Day 2026: How Bicycles Drive Health, Sustainability And Affordable Mobility -
Vibhuvana Sankashti Chaturthi 2026: Significance, Rituals And What Makes This Rare Adhik Maas Vrat Unique -
Chettinad Style Idli Podi Recipe: A Flavorful Breakfast Essential -
Global Running Day 2026: Date, History, and Why the World Laces Up on June 3 -
Horoscope for Today Jun 03, 2026 - Small Steps Lead to Big Gains -
Masala Chai Crowned World’s No.1 Tea In TasteAtlas Top 100 Teas List 2026—India Shines Across Rankings -
Darjeeling Style Thukpa Recipe: A Hearty Noodle Soup -
Sushmita Sen Brings Back 'Chunari Chunari' Vibes Through Ornate Veil Bridal Look
In A New Breakthrough, Mother-Daughter Duo Develops A Vaccine For Alzheimer's Disease
Alzheimer's disease is an irreversible, progressive brain disorder that causes the brain cells to degenerate and die, resulting in a decline in thinking, memory, behavioural and social skills.
According to the Alzheimer's Association, more than 4 million people in India have some form of dementia. It is estimated that at least 44 million people are living with dementia.
New treatments are still under way to stop, slow or prevent Alzheimer's disease and some of them have been unsuccessful.
The brain disorder is caused by the accumulation of plaque deposits in the brain, which eventually becomes toxic to brain cells. These plaque deposits are one of the biggest problems that are coming in the way to finding a cure for Alzheimer's disease because it's impossible to clear out the deposits from the brain tissue.
However, in a very recent breakthrough for Alzheimer's disease, United Neuroscience, a biotech company founded by Dr Chang Yi Wang, a prolific bio-inventor, her daughter Mei Mei Hu, and son-in-law, Louis Reese announced the results of Phase II a clinical trial on UB-311, an Alzheimer's vaccine.
This vaccine contains synthetic versions of amino acid chains that stimulate the antibodies to attack Alzheimer's protein in the blood, without causing any side effects. The antibodies were analysed in some patients and there was an almost 100% response rate.
Researchers believe that the vaccine can delay the onset of Alzheimer's disease by five years.
Currently, the company is working on the next clinical trial of the vaccine and its goal is to create innumerable vaccines that will be used to protect people from chronic illnesses.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications
